Kailash Chadha is the Emeritus Associate Member and Associate Professor of Oncology in the Department of Molecular and Cellular Biology at Roswell Park Cancer Institute. He has 125 publications, written several book chapters, edited a book and currently holds six U.S. patents. His immediate interest is in developing “new” biomarkers in early detection and management of CaP and in studying role PSA in tumor growth & metastasis. His research is being supported by National Cancer Institute, American Cancer Society, National Multiple Sclerosis Society, and EMD Serono Inc.